BaertL.: Controlled double-blind trial of flavoxate in painful conditions of the lower urinary tract. Curr. Med. Res. Opin., 2; 631 (1975).
2.
BradleyD. V., CazortR. J.: Relief of bladder spasm by flavoxate: a comparative study. J. Clin. Pharmacol., 10; 65 (1970).
3.
BradelyW. E.: La neurofisiologica della minzione. Confer. Soc. It. Urodin., Bologna 28.6.1977. Ed. Ente Fiuggi.
4.
BrocklehurstJ. C.: Sperimentazione clinica sull'emepronio bromuro nella nicturia dei vecchi. Brit. Med. J., 2; 216 (1969).
5.
ButtarazziP. J.: Oxybutynin chloride (Ditropan) in enuresis. J. Urol., 118; 46 (1977).
6.
CaineM.: The importance of adrenergic receptors in disorders of micturition. Eur. Urol., 3; 1 (1977).
7.
DelaereK. P. J.: Flavoxate hydrochloride in the treatment of detrusor instability. Urol. Intern., 32; 377 (1977).
8.
DioknoA. C., LapidesJ.: Oxybutynin: a new drug with analgesic and anticholinergic properties. J. Urol., 108; 307 (1972).
9.
DioknoA. C., TaubM.: Ephedrine in treatment of urinary incontinence. Urology, 5; 71 (1975).
10.
DonkerP. J.: Analysis of the urethral pressure profile by means of electromiography and the administration of drugs. Brit. J. Urol., 44; 180 (1972).
11.
FarrarD. J.: A urodynamic analysis of micturition symptoms in the female. Surg., Ginec. & Obst., 141; 875 (1975).
12.
GiacobiniS.: Studio comparativo tra prifinio bromuro (Riabal) e cloruro di ossibutinina (Ditropan) nella terapia della istabilità vescicale. Urologia, 48; 535 (1981).
13.
HebjornS., SteenWalter: Treatment of female incontinence with emepronium bromide. Urol. Intern., 33; 120 (1978).
14.
HilwaN., PerlmutterA. D.: The role of adjunctive drug therapy for intermittent catheterization and self-catheterization in children with vescical dysfunction. J. Urol., 119; 551 (1978).
JonasU.: Effect of flavoxate on hyperactive detrusor muscle. Eur. Urol., 5; 106 (1979).
17.
KaganG.: L'emopronio bromuro nel trattamento della nicturia dei vecchi. Practitioner, 204; 705 (1970).
18.
LaudiM., FontanaG.: Clinical evaluation of a new sinthetic spasmolytic (rociverine) in the urological field. Farmaco, ed. Prat., 34; 553 (1979).
19.
ManganelliA.: Cystometric evaluation of the activity of a new spasmolytic agent-rociverine. Farmaco, ed. Prat., 34; 384 (1979).
20.
MoiseyC. U.: The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. Brit. J. Urol., 52; 472 (1980).
21.
MulcahyJ. J.: Oxybutynin chloride combined with intermittent clean catheterization in the treatment of myelomeningocele patients. J. Urol., 118; 95 (1977).
22.
PansadoroV., PuloneM.: Il cloruro di ossibutinina nella terapia della vescica iperriflessa e dell'urge incontinence. Urologia, 46; 729 (1979).
23.
PaulsonD. F.: Oxybutynin chloride in control of post- transurethral vesical pain and spasm. Urology, 11; 237 (1978).
24.
SyversenJ. H. N.: Emepronium bromide (Cetiprin) as a postoperative spasmolytic agent in transvesical prostatectomy. Scand. J. Urol. & Nephrol, 10; 201 (1976).
25.
ThompsonI. M., LauvetzR.: Oxybutynin in bladder spasm, neurogenic bladder and enuresis. Urology, 8; 452 (1976).
26.
TosonG.: Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity. Arzneimittelforsch., Drug. Res., 28; 1130 (1978).
